Guardant Health (MEX:GH) Interest Expense: MXN-81 Mil (TTM As of Mar. 2026)


MEX:GH Guardant Health Inc MEX:GH
13 GF Score
Price MXN2,590.00
GF Value MXN1,341.84
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Guardant Health Interest Expense?

Guardant Health MEX:GH 13 Interest Expense is MXN-81 Mil as of Mar. 2026. GuruFocus rates MEX:GH with a GF Score™ of 13/100 and a GF Value™ of MXN1,341.84 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Guardant Health's interest expense for the three months ended in Mar. 2026 was MXN -24 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-81 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Guardant Health's Operating Income for the three months ended in Mar. 2026 was MXN -2,188 Mil. Guardant Health's Interest Expense for the three months ended in Mar. 2026 was MXN -24 Mil. Guardant Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Guardant Health  (MEX:GH) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Guardant Health's Interest Expense for the three months ended in Mar. 2026 was MXN-24 Mil. Its Operating Income for the three months ended in Mar. 2026 was MXN-2,188 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was MXN30,232 Mil.

Guardant Health's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Guardant Health did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Guardant Health Interest Expense Historical Data

* Premium members only.

The historical data trend for Guardant Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Interest Expense Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -52.87 -50.24 -43.76 -53.83 -70.17

Guardant Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.18 -18.51 -17.30 -21.25 -24.29
MEX:GH
13GF Score
Guardant Health Inc MEX:GH
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of MXN-81 Mil mean?
Guardant Health (MEX:GH) has a Interest Expense of MXN-81 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Guardant Health and its competitors.
Is Guardant Health's Interest Expense too high?
Guardant Health's current Interest Expense is MXN-81 Mil. Overall, Guardant Health has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Interest Expense compare to LH and DGX?
Guardant Health's Interest Expense of MXN-81 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Diagnostics & Research company?
A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Guardant Health and its competitors. Guardant Health's current Interest Expense is MXN-81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (MEX:GH) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,341.84, compared to a current price of MXN2,590.00 — trading 93% above its estimated fair value. The current Interest Expense is MXN-81 Mil. Guardant Health's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Interest Expense is MXN-81 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,590.00 is trading 93% above its estimated GF Value™ of MXN1,341.84. GuruFocus considers Guardant Health to be Significantly Overvalued.

Key valuation signals for MEX:GH:

  • Interest Expense: MXN-81 Mil
  • GF Value™: MXN1,341.84 vs. price of MXN2,590.00 (93% above fair value)
  • GF Score™: 13/100 with 3 warning signs

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
13GF Score

Get the complete analysis for MEX:GH

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,590.00
Price
MXN1,341.84
GF Value